The role of glucagon-like peptide-1 receptor agonists in cardiovascular disease prevention in type 2 diabetes mellitus: evidence from the most recent clinical trials.

Ann Transl Med · 2018

Last updated 2026-05-28

Journal	Ann Transl Med, 2018
Citations	1
Relative citation ratio	0.05
NIH percentile	5
Molecules	—
Conditions studied	Type 2 Diabetes, Cardiovascular Risk Reduction

Full record and abstract on PubMed 29951516 ↗